Sodium Acetate Injection Shortage: Current Availability and Manufacturer Updates

Drug Shortages low FDA · · United States

The FDA reports an ongoing shortage of Sodium Acetate Injection, used in Total Parenteral Nutrition, though Fresenius Kabi USA currently reports product availability.

Sodium Acetate Injection Shortage Update

What’s in Shortage

Generic Name: Sodium Acetate Injection
Brand Name: SODIUM ACETATE
Dosage Form: Injection
Therapeutic Category: Total Parenteral Nutrition
Current Status: Current Shortage
Initial Posting Date: March 23, 2016
Last Updated: February 5, 2026

Which Manufacturers Are Affected

The following manufacturer is listed in the FDA database regarding this shortage:

  • Fresenius Kabi USA, LLC
    • Status: Available
    • Presentation: Sodium Acetate, Injection, 4 meq/100 mL (NDC 63323-032-00)
    • Notes: The manufacturer advises checking wholesalers for current inventory.
    • Contact Information: 888-386-1300

Why There’s a Shortage

No specific reason for the shortage was provided in the source data.

What Patients Should Do

If you or a loved one relies on Sodium Acetate Injection as part of Total Parenteral Nutrition, please consider the following steps:

  • Consult Your Healthcare Provider: Discuss your treatment plan with your doctor. Do not make any changes to your medical regimen without professional guidance.
  • Talk to Your Pharmacist: Pharmacists can provide real-time updates on local stock and may be able to coordinate with wholesalers to secure supply.
  • Contact the Manufacturer: For specific questions regarding supply, you may reach Fresenius Kabi USA at 888-386-1300.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Patients should always consult with their healthcare provider regarding medication changes or alternatives.

Source

Attribution: FDA Drug Shortage Database